Sign in
4

Changes in Ownership

agilon health, inc. Filed Acc 0001209191-22-025160

Chief Strategy & Dev. Officer sold 212,714 shares at an average $22.54 ($4,794,574)

  • Chief Strategy & Dev. Officer acquired 212,714 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Desai Veeral · Chief Strategy & Dev. Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-19 Exercise or conversion : show line 1 in the form +106,357 $1.00 $106,357 384,568 D
2022-04-19 Sale : show line 2 in the form −106,357 $22.74 $2,418,558 278,211 D
2022-04-20 Exercise or conversion : show line 3 in the form +106,357 $1.00 $106,357 384,568 D
2022-04-20 Sale : show line 4 in the form −106,357 $22.34 $2,376,015 278,211 D
Open-market sales · 212,714 sh · avg $22.54 · $4,794,574

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-04-19 Exercise or conversion : show line 5 in the form Options (Rights to Buy) −106,357 775,351 D
2022-04-20 Exercise or conversion : show line 6 in the form Options (Rights to Buy) −106,357 668,994 D
Loading xslF345X03/doc4.xml…